Back to search

Article

Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring

2022-11-02

Abstract excerpt

<h4>Background: </h4> Determination of programmed death-ligand 1 (PD-L1) protein expression level in tumor cells and tumor-associated immune cells is critical for identifying patients eligible for immunotherapy. PD-L1 manual scoring algorithms can generally be divided into two categories: cell counting and visual estimation. Cell counting can be time-consuming and is not in sync with pathology practice, which clas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2e5d963b-5f3e-5c03-a897-d74e31829675
DOI
10.21203/rs.3.rs-2206120/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoringDOI 10.21203/rs.3.rs-2206120/v1
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.Semantic proximity
Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software.Semantic proximity
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapySemantic proximity
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.Semantic proximity
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial Orchestration.Semantic proximity
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupSemantic proximity
Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue TypesSemantic proximity
Light weight deep learning-based auto-quantification system for bright-filed HER2 dual in situ hybridization image analysisSemantic proximity
Rapid intraoperative immunohistochemistry (RD-IHC) is a useful tool in intraoperative pathologic diagnosisSemantic proximity
One label is all you need: Interpretable AI-enhanced histopathology for oncologySemantic proximity
What does PD-L1 positive or negative mean?Semantic proximity
Automated detection of Kaposi sarcoma-associated herpesvirus infected cells in immunohistochemical images of skin biopsiesSemantic proximity
Select a neighboring publication to make it the new centre.